当前位置： SCI文献检索 > BMC CANCER期刊下所有文献 > Effects of leucine supplemented diet on intestinal absorption in tumor bearing pregnant rats.

Effects of leucine supplemented diet on intestinal absorption in tumor bearing pregnant rats.

Abstract：

BACKGROUND:It is known that amino acid oxidation is increased in tumor-bearing rat muscles and that leucine is an important ketogenic amino acid that provides energy to the skeletal muscle. METHODS:To evaluate the effects of a leucine supplemented diet on the intestinal absorption alterations produced by Walker 256, growing pregnant rats were distributed into six groups. Three pregnant groups received a normal protein diet (18% protein): pregnant (N), tumor-bearing (WN), pair-fed rats (Np). Three other pregnant groups were fed a diet supplemented with 3% leucine (15% protein plus 3% leucine): leucine (L), tumor-bearing (WL) and pair-fed with leucine (Lp). Non pregnant rats (C), which received a normal protein diet, were used as a control group. After 20 days, the animals were submitted to intestinal perfusion to measure leucine, methionine and glucose absorption. RESULTS:Tumor-bearing pregnant rats showed impairment in food intake, body weight gain and muscle protein content, which were less accentuated in WL than in WN rats. These metabolic changes led to reduction in both fetal and tumor development. Leucine absorption slightly increased in WN group. In spite of having a significant decrease in leucine and methionine absorption compared to L, the WL group has shown a higher absorption rate of methionine than WN group, probably due to the ingestion of the leucine supplemented diet inducing this amino acid uptake. Glucose absorption was reduced in both tumor-bearing groups. CONCLUSIONS:Leucine supplementation during pregnancy in tumor-bearing rats promoted high leucine absorption, increasing the availability of the amino acid for neoplasic cells and, mainly, for fetus and host utilization. This may have contributed to the better preservation of body weight gain, food intake and muscle protein observed in the supplemented rats in relation to the non-supplemented ones.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Ventrucci G,de Mello MA,Gomes-Marcondes MC

doi

10.1186/1471-2407-2-7

keywords:

subject

Has Abstract

pub_date

2002-04-15 00:00:00

pages

7

issn

1471-2407

journal_volume

2

pub_type

杂志文章

相关文献

BMC CANCER文献大全
  • Statin use and association with colorectal cancer survival and risk: case control study with prescription data linkage.

    abstract：BACKGROUND:In Scotland colorectal cancer (CRC) is the third most common cancer and a leading cause of cancer death. Epidemiological studies have reported conflicting associations between statins and CRC risk and there is one published report of the association between statins and CRC survival. METHODS:Analysis was car...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-12-487

    authors： Lakha F,Theodoratou E,Farrington SM,Tenesa A,Cetnarskyj R,Din FV,Porteous ME,Dunlop MG,Campbell H

    更新日期：2012-10-22 00:00:00

  • p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells.

    abstract：BACKGROUND:Histone acetyltransferase p300 is a crucial transcriptional coactivator and has been implicated as a poor prognostic factor in human cancers. However, little is known about the substantial functions and mechanisms of p300 in NSCLC proliferation and distant metastasis. METHODS:We constructed p300 down-regula...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-4559-3

    authors： Hou X,Gong R,Zhan J,Zhou T,Ma Y,Zhao Y,Zhang Y,Chen G,Zhang Z,Ma S,Chen X,Gao F,Hong S,Luo F,Fang W,Yang Y,Huang Y,Chen L,Yang H,Zhang L

    更新日期：2018-06-07 00:00:00

  • The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer.

    abstract：BACKGROUND:Whether PET scan maximum standard uptake value (SUVmax) could differentiate luminal A from luminal B and help predict the survival of metastatic breast cancer (MBC) patients with luminal subtype is still unknown and need to be investigated. METHODS:305 MBC patients with luminal subtypes were screened with P...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-13-42

    authors： Zhang J,Jia Z,Ragaz J,Zhang YJ,Zhou M,Zhang YP,Li G,Wang BY,Wang ZH,Hu XC

    更新日期：2013-01-31 00:00:00

  • miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).

    abstract：BACKGROUND:Hepatocellular carcinoma (HCC) is a lethal disease, while the precise underlying molecular mechanisms of HCC pathogenesis remain to be defined. MicroRNA (miRNA), a class of non-coding small RNAs, can post-transcriptionally regulate gene expression. Altered miRNA expression has been reported in HCCs. This stu...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-016-2801-4

    authors： Zhu Q,Gong L,Wang J,Tu Q,Yao L,Zhang JR,Han XJ,Zhu SJ,Wang SM,Li YH,Zhang W

    更新日期：2016-10-18 00:00:00

  • miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.

    abstract：BACKGROUND:Wilms' tumor is also called nephroblastoma and is the most common pediatric renal cancer. Several genetic and epigenetic factors have been found to account for the development of Wilms' tumor. MiRNAs play important roles in this tumorigenic process. In the present study, we aimed to investigate the role of m...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-019-5609-1

    authors： Liu Z,He F,OuYang S,Li Y,Ma F,Chang H,Cao D,Wu J

    更新日期：2019-04-29 00:00:00

  • Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy.

    abstract：BACKGROUND:We evaluated the hierarchical risk groups for the estimated survival of WHO grade III glioma patients using recursive partitioning analysis (RPA). To our knowledge, this is the first study to address the results of RPA specifically for WHO grade III gliomas. METHODS:A total of 133 patients with anaplastic a...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-9-450

    authors： Park CK,Lee SH,Han JH,Kim CY,Kim DW,Paek SH,Kim DG,Heo DS,Kim IH,Jung HW

    更新日期：2009-12-18 00:00:00

  • A prospective study on histone γ-H2AX and 53BP1 foci expression in rectal carcinoma patients: correlation with radiation therapy-induced outcome.

    abstract：BACKGROUND:The prognostic value of histone γ-H2AX and 53BP1 proteins to predict the radiotherapy (RT) outcome of patients with rectal carcinoma (RC) was evaluated in a prospective study. High expression of the constitutive histone γ-H2AX is indicative of defective DNA repair pathway and/or genomic instability, whereas ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-015-1890-9

    authors： Djuzenova CS,Zimmermann M,Katzer A,Fiedler V,Distel LV,Gasser M,Waaga-Gasser AM,Flentje M,Polat B

    更新日期：2015-11-06 00:00:00

  • Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line.

    abstract：BACKGROUND:Triptolide induces apoptosis and DNA damage followed by inhibition of DNA repair associated gene expression. However, there is the limited data for biomarker to predict the benefit to triptolide in various cancers including pancreatic cancer. METHODS:We investigated the anti tumor efficacy of triptolide in ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-4995-0

    authors： Kim ST,Kim SY,Lee J,Kim K,Park SH,Park YS,Lim HY,Kang WK,Park JO

    更新日期：2018-11-12 00:00:00

  • Correction to: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma.

    abstract：:Following publication of the original article [1], the authors reported the family name of the second author was incorrectly published. ...

    journal_title：BMC cancer

    pub_type： 已发布勘误

    doi：10.1186/s12885-019-6048-8

    authors： Doma V,Kárpáti S,Rásó E,Barbai T,Tímár J

    更新日期：2019-08-29 00:00:00

  • ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.

    abstract：BACKGROUND:Hepatocellular carcinoma (HCC) represents a highly vascularized tumor entity and the process of angiogenesis is essential for the growth of HCC. Importantly, the pro-angiogenic transcription factors HIF-1alpha and STAT3 have been implicated in HCC progression, thus representing interesting targets for molecu...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-8-206

    authors： Moser C,Lang SA,Mori A,Hellerbrand C,Schlitt HJ,Geissler EK,Fogler WE,Stoeltzing O

    更新日期：2008-07-23 00:00:00

  • Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.

    abstract：BACKGROUND:Glioblastoma (GBM) tumors exhibit strong phenotypic differences that can be quantified using magnetic resonance imaging (MRI), but the underlying biological drivers of these imaging phenotypes remain largely unknown. An Imaging-Genomics analysis was performed to reveal the mechanistic associations between MR...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-016-2659-5

    authors： Grossmann P,Gutman DA,Dunn WD Jr,Holder CA,Aerts HJ

    更新日期：2016-08-08 00:00:00

  • Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.

    abstract：BACKGROUND:The epithelial cell adhesion molecule (EpCAM) has been shown to be overexpressed in breast cancer and stem cells and has emerged as an attractive target for immunotherapy of breast cancer patients. This study analyzes the effects of EpCAM on breast cancer cell lines with epithelial or mesenchymal phenotype. ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-12-501

    authors： Martowicz A,Spizzo G,Gastl G,Untergasser G

    更新日期：2012-10-30 00:00:00

  • The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma.

    abstract：BACKGROUND:Malignant Pleural Mesothelioma (MPM) is an aggressive tumor arising from mesothelial cells lining the pleural cavities characterized by resistance to standard therapies. Most of the molecular steps responsible for pleural transformation remain unclear; however, several growth factor signaling cascades are kn...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-015-1363-1

    authors： Pignochino Y,Dell'Aglio C,Inghilleri S,Zorzetto M,Basiricò M,Capozzi F,Canta M,Piloni D,Cemmi F,Sangiolo D,Gammaitoni L,Soster M,Marchiò S,Pozzi E,Morbini P,Luisetti M,Aglietta M,Grignani G,Stella GM

    更新日期：2015-05-08 00:00:00

  • ATF-3/miR-590/GOLPH3 signaling pathway regulates proliferation of breast cancer.

    abstract：BACKGROUND:Breast cancer is one of the leading causes of death in women worldwide. Fast growth is the important character of breast cancer, which makes sure the subsequent metastasize and invasion breast cancer. Golgi related genes GOLPH3 has been reported to regulate many kinds of cancers proliferation. However, its u...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-4031-4

    authors： Song Q,Chen Q,Wang Q,Yang L,Lv D,Jin G,Liu J,Li B,Fei X

    更新日期：2018-03-09 00:00:00

  • Skin cancers in people with albinism in Togo in 2019: results of two rounds of national mobile skin care clinics.

    abstract：BACKGROUND:In people with albinism (PWA), the deficiency of melanin increase the risk of skin cancers. The aim of this study was to determine the prevalence of skin cancers and characteristics of these detected skin cancers (histological types, localization) in PWA in 10 cities in Togo in 2019. METHODS:This is a cross...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-020-07747-8

    authors： Saka B,Akakpo SA,Teclessou JN,Gnossike P,Adam S,Mahamadou G,Kassang P,Elegbede Y,Mouhari-Toure A,Darre T,Kombate K,Pitché P

    更新日期：2021-01-05 00:00:00

  • Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial.

    abstract：BACKGROUND:There is no consensus on the therapeutic approach to ECOG 2 patients with locally advanced non-small-cell lung cancer (LA-NSCLC), despite the sizable percentage of these patients in clinical practice. This study focused on the efficacy, toxicity and the optimal chemotherapy regimen of CCRT in ECOG 2 patients...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-020-06780-x

    authors： Bi N,Liu L,Liang J,Wu S,Chen M,Lv C,Zhao L,Shi A,Jiang W,Xu Y,Zhou Z,Wang J,Wang W,Chen D,Hui Z,Lv J,Zhang H,Feng Q,Xiao Z,Wang X,Zhang T,Yin W,Li J,He J,Wang L

    更新日期：2020-04-06 00:00:00

  • Association of MTHFR gene polymorphisms with breast cancer survival.

    abstract：BACKGROUND:Two functional single nucleotide polymorphisms (SNPs) in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene, C677T and A1298C, lead to decreased enzyme activity and affect chemosensitivity of tumor cells. We investigated whether these MTHFR SNPs were associated with breast cancer survival in African-A...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-6-257

    authors： Martin DN,Boersma BJ,Howe TM,Goodman JE,Mechanic LE,Chanock SJ,Ambs S

    更新日期：2006-10-27 00:00:00

  • Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib.

    abstract：BACKGROUND:Tyrosine kinase inhibitors (TKIs) are currently approved for the treatment of metastatic renal cell carcinoma (mRCC). The cardiotoxic effects of sorafenib and sunitinib may cause hypertension, left ventricular ejection fraction (LVEF) dysfunction and/or congestive heart failure (CHF), and arterial thrombo-em...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-12-231

    authors： Pantaleo MA,Mandrioli A,Saponara M,Nannini M,Erente G,Lolli C,Biasco G

    更新日期：2012-06-11 00:00:00

  • Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis.

    abstract：BACKGROUND:Vascular endothelial growth factor (VEGF) is a potent mitogen for endothelial cells, and its expression has been correlated with increased tumour angiogenesis. Although numerous publications dealing with the measurement of circulating VEGF for diagnostic and therapeutic monitoring have been published, the re...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-5-128

    authors： Cressey R,Wattananupong O,Lertprasertsuke N,Vinitketkumnuen U

    更新日期：2005-10-04 00:00:00

  • Differential knockdown of TGF-β ligands in a three-dimensional co-culture tumor- stromal interaction model of lung cancer.

    abstract：BACKGROUND:Transforming growth factor (TGF)-β plays a pivotal role in cancer progression through regulating cancer cell proliferation, invasion, and remodeling of the tumor microenvironment. Cancer-associated fibroblasts (CAFs) are the predominant type of stromal cell, in which TGF-β signaling is activated. Among the s...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-14-580

    authors： Horie M,Saito A,Noguchi S,Yamaguchi Y,Ohshima M,Morishita Y,Suzuki HI,Kohyama T,Nagase T

    更新日期：2014-08-09 00:00:00

  • Breast cancer primary tumor ER expression pattern predicts its expression concordance in matched synchronous lymph node metastases.

    abstract：BACKGROUND:Estrogen receptor (ER) expression is important for treatment selection and prognostication of breast cancer patients. Although the metastases are the main targets of endocrine therapy, ER status is often based on the primary tumor. However, ER expression in breast cancer primary lesion may not match with its...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-5217-5

    authors： Zhao J,Hu C,Wang C,Yu W,Guo Y,Shi M,Shui Y,Wei Q

    更新日期：2018-12-27 00:00:00

  • Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.

    abstract：BACKGROUND:BRCA1 and BRCA2 mutations explain approximately one-fifth of the inherited susceptibility in high-risk Finnish hereditary breast and ovarian cancer (HBOC) families. EMSY is located in the breast cancer-associated chromosomal region 11q13. The EMSY gene encodes a BRCA2-interacting protein that has been implic...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-017-3488-x

    authors： Määttä KM,Nurminen R,Kankuri-Tammilehto M,Kallioniemi A,Laasanen SL,Schleutker J

    更新日期：2017-07-24 00:00:00

  • Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective ca

    abstract：BACKGROUND:To determine the safety and efficacy of transarterial chemoembolization (TACE) combined with radiofrequency ablation (hereafter, TACE-RFA) in treating Barcelona Clinic Liver Cancer (BCLC) Stage A or B (hereafter, BCLC A/B) hepatocellular carcinoma (HCC) patients, and to explore the range of tumor sizes suita...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-019-6237-5

    authors： Ren Y,Cao Y,Ma H,Kan X,Zhou C,Liu J,Shi Q,Feng G,Xiong B,Zheng C

    更新日期：2019-10-22 00:00:00

  • Interaction of translationally controlled tumor protein with Apaf-1 is involved in the development of chemoresistance in HeLa cells.

    abstract：BACKGROUND:Translationally controlled tumor protein (TCTP), alternatively called fortilin, is believed to be involved in the development of the chemoresistance of tumor cells against anticancer drugs such as etoposide, taxol, and oxaliplatin, the underlying mechanisms of which still remain elusive. METHODS:Cell death ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-14-165

    authors： Jung J,Kim HY,Maeng J,Kim M,Shin DH,Lee K

    更新日期：2014-03-07 00:00:00

  • Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma.

    abstract：BACKGROUND:Uterine carcinosarcoma (UCS) represents a true example of cancer associated with epithelial-mesenchymal transition (EMT), which exhibits cancer stem cell (CSC)-like traits. Both Sox and β-catenin signal transductions play key roles in the regulation of EMT/CSC properties, but little is known about their invo...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-016-2090-y

    authors： Inoue H,Takahashi H,Hashimura M,Eshima K,Akiya M,Matsumoto T,Saegusa M

    更新日期：2016-02-03 00:00:00

  • CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy.

    abstract：BACKGROUND:Doxorubicin-based chemotherapy is currently the most frequently used treatment for triple negative breast cancer (TNBC), yet the response rate is not high due to the lack of a biomarker allowing identification of responsive patients before the chemotherapy is initiated. We have demonstrated that doxorubicin ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-4724-8

    authors： Denard B,Jiang S,Peng Y,Ye J

    更新日期：2018-08-13 00:00:00

  • Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study.

    abstract：BACKGROUND:Phase 3 studies suggest that induction chemotherapy (ICT) of cisplatin and 5-fluorouracil plus docetaxel (TPF) is effective but toxic for patients with squamous-cell carcinoma of the head and neck (SCCHN). Dose-dense chemotherapy may yield favorable outcomes compared with standard-dose chemotherapy, yet the ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-020-07347-6

    authors： Hsieh CY,Lein MY,Yang SN,Wang YC,Lin YJ,Lin CY,Hua CH,Tsai MH,Lin CC

    更新日期：2020-09-01 00:00:00

  • ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).

    abstract：BACKGROUND:Recent randomized controlled trials comparing neoadjuvant chemoradiation plus surgery or perioperative chemotherapy plus surgery with surgery alone showed significant survival benefits for combined modality treatment of patients with localized esophageal adenocarcinoma. However, head-to-head comparisons of n...

    journal_title：BMC cancer

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1186/s12885-016-2564-y

    authors： Hoeppner J,Lordick F,Brunner T,Glatz T,Bronsert P,Röthling N,Schmoor C,Lorenz D,Ell C,Hopt UT,Siewert JR

    更新日期：2016-07-19 00:00:00

  • The feasibility and advantage of uniportal video-assisted thoracoscopic surgery (VATS) in pulmonary lobectomy.

    abstract：BACKGROUND:Ongoing improvements in technique and instruments for video-assisted thoracoscopic surgery (VATS) have made minimally-invasive uniportal VATS lobectomy a reality. However, the outcomes of the procedure are still under investigation, and at present, uniportal VATS lobectomy is performed infrequently at most h...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-017-3069-z

    authors： Wang L,Liu D,Lu J,Zhang S,Yang X

    更新日期：2017-01-25 00:00:00

  • SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.

    abstract：BACKGROUND:Association between rectal or colon cancer risk and serine hydroxymethyltransferase 1 (SHMT1) C1420T or methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms was assessed. The serum total homocysteine (HCY), marker of folate metabolism was also investigated. METHODS:The SHMT1 and MTHFR genotypes w...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-10-525

    authors： Komlósi V,Hitre E,Pap E,Adleff V,Réti A,Székely E,Bíró A,Rudnai P,Schoket B,Müller J,Tóth B,Ottó S,Kásler M,Kralovánszky J,Budai B

    更新日期：2010-10-04 00:00:00